Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Werner

Showing results (131-140 of 151) with videos related to

Pageof 16
Sort By:
Clinical Nuclear Medicine|January 14, 2025
The Value of Multidisciplinary Neuro-oncological Tumor Boards to Increase the Accuracy of FET PET for Identifying Brain Tumor RelapseGarry S Ceccon, Jan-Michael Werner, Maximilian I Ruge, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2020
Treatment Monitoring of Immunotherapy and Targeted Therapy Using <sup>18</sup>F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial ExperiencesNorbert Galldiks, Diana S Y Abdulla, Matthias Scheffler, et al.
Neuro-Oncology|August 26, 2025
Prognostic stratification of newly diagnosed IDH-mutant gliomas by [18F]fluoroethyltyrosine and [11C]methionine PET - a retrospective, bicentric cohort studyMaximilian J Mair, Jan-Michael Werner, Jonathan Weller, et al.
Neurogenetics|December 10, 2014
Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal modelsAlejandro Leal, Kathrin Huehne, Finn Bauer, et al.
Neurogenetics|March 18, 2009
Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal modelsAlejandro Leal, Kathrin Huehne, Finn Bauer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 17, 2025
Clinical potential of [<sup>18</sup>F]FET PET in patients with circumscribed astrocytic gliomaJan-Michael Werner, Maximilian J Mair, Michael M Wollring, et al.
Current Biology : CB|September 18, 2012
Specialization of mutualistic interaction networks decreases toward tropical latitudesMatthias Schleuning, Jochen Fründ, Alexandra-Maria Klein, et al.
Nature Medicine|May 9, 2025
RANO criteria for response assessment of brain metastases based on amino acid PET imagingNathalie L Albert, Norbert Galldiks, Benjamin M Ellingson, et al.
Nature Medicine|June 9, 2025
Author Correction: RANO criteria for response assessment of brain metastases based on amino acid PET imagingNathalie L Albert, Norbert Galldiks, Benjamin M Ellingson, et al.
Ecology Letters|June 23, 2015
Land use intensification alters ecosystem multifunctionality via loss of biodiversity and changes to functional compositionEric Allan, Pete Manning, Fabian Alt, et al.
Pageof 16

Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
Clinical Nuclear Medicine|January 14, 2025
The Value of Multidisciplinary Neuro-oncological Tumor Boards to Increase the Accuracy of FET PET for Identifying Brain Tumor RelapseGarry S Ceccon, Jan-Michael Werner, Maximilian I Ruge, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2020
Treatment Monitoring of Immunotherapy and Targeted Therapy Using <sup>18</sup>F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial ExperiencesNorbert Galldiks, Diana S Y Abdulla, Matthias Scheffler, et al.
Neuro-Oncology|August 26, 2025
Prognostic stratification of newly diagnosed IDH-mutant gliomas by [18F]fluoroethyltyrosine and [11C]methionine PET - a retrospective, bicentric cohort studyMaximilian J Mair, Jan-Michael Werner, Jonathan Weller, et al.
Neurogenetics|December 10, 2014
Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal modelsAlejandro Leal, Kathrin Huehne, Finn Bauer, et al.
Neurogenetics|March 18, 2009
Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal modelsAlejandro Leal, Kathrin Huehne, Finn Bauer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 17, 2025
Clinical potential of [<sup>18</sup>F]FET PET in patients with circumscribed astrocytic gliomaJan-Michael Werner, Maximilian J Mair, Michael M Wollring, et al.
Current Biology : CB|September 18, 2012
Specialization of mutualistic interaction networks decreases toward tropical latitudesMatthias Schleuning, Jochen Fründ, Alexandra-Maria Klein, et al.
Nature Medicine|May 9, 2025
RANO criteria for response assessment of brain metastases based on amino acid PET imagingNathalie L Albert, Norbert Galldiks, Benjamin M Ellingson, et al.
Nature Medicine|June 9, 2025
Author Correction: RANO criteria for response assessment of brain metastases based on amino acid PET imagingNathalie L Albert, Norbert Galldiks, Benjamin M Ellingson, et al.
Ecology Letters|June 23, 2015
Land use intensification alters ecosystem multifunctionality via loss of biodiversity and changes to functional compositionEric Allan, Pete Manning, Fabian Alt, et al.
Pageof 16